Nutriband Inc (NTRBW)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced...

Form 8-K - Current report

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl...

Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica

ORLANDO, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today...

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today...

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. today announced that it has signed an...

Form 8-K - Current report

Form 8-K - Current report

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has provided...

Nutriband CEO Publishes Letter to Shareholders

ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced...

Form 8-K - Current report